The novel nitric oxide-donating bimatoprost eye drop is being clinically developed for the lowering of IOP in patients with ...

Learn to spot early warning signs from your eyes that may signal serious health issues and protect your vision before it's ...

The biotech company, focused on developing treatments for chronic eye conditions, received Food and Drug Administration (FDA) ...

UBX1325 is a novel BCL-xL inhibitor designed to eliminate senescent cells in diabetic retinal blood vessels, while leaving ...

Galegenimab, an anti-HtrA1 antibody, does not slow the progression of geographic atrophy, according to research published in the American Journal of Ophthalmology.